Tus kws kho mob
P51-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2361 - 2370 ntawm 3159
Tus kws kho mob
2020 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P47-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 31, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P50-20 eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P49-20 CERiS Review of High Dollar Claims
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
QP31R1-20 Update: Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP54-20 MHCP Pharmacy Benefit Update — Pharmacy Benefit Exclusion for Nexplanon® and Trodelvy™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP57-20 Commercial Pharmacy Benefit Update: Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP53-20 Commercial Pharmacy Benefit Exclusion for Nexplanon®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP56-20 U.S. Department of Health and Human Services Announced Additional Opportunity for Funding
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020